We also tested MSC/GM-CSF in a colorectal carcinoma murine model finding a significant decrease in tumour growth, suggesting that MSCs expressing GM-CSF could be used in other gastrointestinal tumours. The gene discussed is CSF2; the disease is neoplasm.